Tagged with

Torrex Chiesi Poland Would you begin by explaining to the readers of Pharmaceutical Executive the importance of the operation in Poland for the company? Indeed Poland because of largest in CEE pharmaceutical market size was always very attractive for all pharmaceutical companies, although it is a very complex market. For those coming to…

Johnson&Johnson Romania In order to provide our readers with a general idea of the current state of the Romanian pharmaceutical and healthcare sectors, can you first of all elaborate on the key particularities of this market? Romania has been a member of the EU since 2009, is a potential member of the…

Nycomed Poland As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous year, but still managed to grow by 3,3% according to IMS data, which is in line with the market. This…

Quintiles Poland Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal medicine and intensive care departments of the Warsaw medical school. The team there was already conducting some medical research in the clinic.…

Servier China Servier was one of the first pharmaceutical companies to establish a presence in China back in 1979. How has Servier’s presence evolved alongside China’s huge transformations of the last decades? Indeed, we are very proud to be one of the pioneering foreign companies in China’s pharmaceutical market. The year was…

Ipsen Poland When we look at the full year 2010 unaudited IFRS consolidated sales, we see that Ipsen performed very well in 2010 in Central and Eastern Europe. How has Poland alone performed in the same period? It is my personal privilege and pride to say that 2010 was an extremely good…

Eli Lilly Polska You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are co-chairing the LAWG – Local Area Working Group – a group of R&D based pharmaceutical companies in Poland, since July 2010, so 2010 was a…

Array The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable, approximating 10% year on year. The market size is over five billion Euros which makes Poland the sixth biggest market in Europe. What are main the competitive advantages do you see in the Polish market…

Espacio Riesco You are by far the largest Convention Centre in Chile. When was it decided to construct such an impressive event area and what was the vision behind the creation of Espacio Riesco? The idea of Espacio Riesco came up in 1998 and the first phase of the construction ended in…

Servier China In 2012 Servier China became the 3rd largest affiliate within the Servier group. How has the company progressed since then? Servier-China is a linchpin for Servier. Servier-China has become the biggest subsidiary in terms of personnel, with over 1200 people, and today we are number one in the Company in…

GlaxoSmithKline pharmaceuticals S.A. In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your entire professional career to GlaxoSmithKline (GSK), that you joined in 1992. What has kept you within the group, what has…

Lundbeck China Since this interview, Michael Ryde has left Lundbeck China and is now working as Commercial Counsellor, Teamleader Health, at the Danish Embassy in Beijing. Oscar Parra currently holds the position of General Manager for Lundbeck China. Lundbeck originally sold its products in China exclusively through partners for several years. What…